People

Read his academic papers on PubMed, Google Scholar, and arXiv, dissertation on ProQuest, and popular writings on Vector. In his free time, he likes to carry out elaborate experiments in the kitchen, with his kids serving as cooking research participants; some recipes on Vox Over.

Casie received her BA in Human Ecology from the College of the Atlantic and studied at North Carolina State University for her MS in Plant Biology. Prior to graduate school, she studied with Alex in Tom Look’s lab at the Dana-Farber Cancer Institute. Casie is currently studying the role of DNA transposition in solid tumors.

Lauren is a graduate student in the Sloan Kettering-Weill Cornell Pharmacology program. She received her B.S. and M.S. in Microbiology at the University of Rochester where her research was focused on antibiotic drug discovery. Her current research interests include cancer therapeutics and drug design.

Mike is a clinical pediatric hematologist & oncologist at MSKCC and Weill Cornell Medical College. Prior to joining the KRG, he studied bioengineering at Cornell University, received his MD from the University of Florida, and completed his pediatrics residency at Children’s National in Washington, DC. Mike’s current research focuses on developing novel therapeutics for relapsed Wilms tumors and SWI/SNF-mutant sarcomas.

He graduated from Padua University (Italy) before moving to Lund University (Sweden) to obtain his PhD. His research is mainly focused on applying targeted MS approaches to functional proteomics and on cancer-specific post-translational modifications. He is an AICF fellow.

Zheng is a graduate student in the Tri-Institutional Program in Chemical Biology. He received his B.A. at Cornell University with a double major in Chemistry and Biology, where his research focused on cancer metabolomics. His current research interests are focused on cancer proteomics. Zheng is supported by a NSS-PhD scholarship from A*STAR, Singapore.

Sumiko received her MD and PhD from Kyoto University. She is interested in the biology and therapy of acute myeloid leukemia. Currently, she is modeling refractory childhood leukemias using genetically-engineered mouse models and developing methods for profiling and targeting leukemia stem cells.

Shehana received her B.S. from the University of California, Riverside in Biology and M.S. from the New York University, investigating developmental genetics in C. elegans. She is interested in genome editing approaches to define mechanisms and functions of genome remodeling factors.